Quarry »

Inhibikase Therapeutics shares owned by Quarry

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Quarry from 13F filings

Historical chart of Quarry investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Quarry consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Quarry

Quarter filed Position value Share count Share price at filing
2026-06-30 $112 55 2.04

More positions owned by Quarry

Space Exploration Techn Corp Class A Com Stk (SPCX)
Marvell Technology (MRVL)
Cornerstone Strategic Value (CLM)
Chart Industries (GTLS)
Warner Bros Discovery Com Ser A (WBD)
Kenvue (KVUE)
Penumbra (PEN)
Norfolk Southern (NSC)
Cornerstone Total Rtrn Fd In (CRF)
Roku Com Cl A (ROKU)
UniFirst Corporation (UNF)
Topbuild
Cantor Equity Partners I Shs Cl A (CEPO)
Inflection Pt Acquisition Cl A Ord Shs (IPCX)
Qorvo (QRVO)

View all positions for Quarry

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Trails Edge Capital Partners
Fairmount Funds Management
BlackRock
ADAR1 Capital Management
Blackstone Group
Siren
Commodore Capital
Vanguard Capital Management
Millennium Management
Saturn V Capital Management
Kalehua Capital Management
Spruce Street Capital
Squadron Capital Management

View all funds holding Inhibikase Therapeutics